We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OBIO market cap is 232.34M. The company's latest EPS is USD -1.3742 and P/E is -5.07.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 0 | 0 | 0 | 1.16M | 915k |
Operating Income | -938k | -813k | -877k | -11.55M | -12.96M |
Net Income | -735k | -685k | -877k | -10.94M | -12.05M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 2.76M |
Operating Income | -180k | -395k | -3.08M | -51.51M |
Net Income | -174k | -379k | -2.74M | -49.12M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 161.58M | 68.65M | 68.08M | 136.28M | 125.88M |
Total Liabilities | 6.7M | 7.04M | 7.34M | 36.53M | 36.44M |
Total Equity | -5.26M | -6.07M | -6.95M | 99.75M | 89.44M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 162.16M | 161.82M | 68.08M | 95.21M |
Total Liabilities | 5.72M | 5.77M | 7.34M | 27.17M |
Total Equity | 5M | -3.94M | -6.95M | 68.04M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -447k | -1.02M | -1.58M | -14.38M | -24.87M |
Investing | N/A | 92.59M | 92.59M | -43.53M | -35.41M |
Financing | N/A | -92.59M | -92.59M | 56.82M | 56.91M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -259k | -273k | -1.58M | -46.13M |
Investing | -160M | N/A | 92.59M | 10.69M |
Financing | 162.29M | N/A | -92.59M | 46.22M |
Market Cap | 232.34M |
Price to Earnings Ratio | -5.07 |
Price to Sales Ratio | 90.28 |
Price to Cash Ratio | 8.15 |
Price to Book Ratio | 3.66 |
Dividend Yield | - |
Shares Outstanding | 35.74M |
Average Volume (1 week) | 30.5k |
Average Volume (1 Month) | 32.25k |
52 Week Change | -56.61% |
52 Week High | 17.35 |
52 Week Low | 4.22 |
Spread (Intraday) | 0.78 (11.14%) |
Company Name | Orchestra BioMed Holdings Inc |
Address |
po box 309 grand cayman KY1 1104 |
Website | https:// |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions